Prevalence and predictors of pulmonary artery hypertension in systemic sclerosis

Journal of Association of Physicians of India

Volumn 56, Issue JUNE, 2008, Pages 413-417

  Kumar, Uma ^a   Ramteke, R ^a   Yadav, R ^a   Ramam, M ^a   Handa, Rohini ^a   Kumar, A ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FORECASTING; HUMAN; INDIA; MALE; MIDDLE AGED; ONSET AGE; PREVALENCE; PULMONARY ARTERY; PULMONARY HYPERTENSION; SEX DIFFERENCE; STATISTICAL MODEL; SYSTEMIC SCLEROSIS; TRICUSPID VALVE REGURGITATION;

ADULT; AGE OF ONSET; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; FORECASTING; HUMANS; HYPERTENSION, PULMONARY; INDIA; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY ARTERY; SCLERODERMA, SYSTEMIC; SEX FACTORS; TRICUSPID VALVE INSUFFICIENCY;

EID: 44649194498     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Denton CP, Black CM, Abraham DJ. Mechanism and consequence of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol 2006;2:134-44.
2. Simonneau G, Galiè N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43:5S-12S.
3. Kawut SM, Taichman DB, Archer- Chicko CL, Palevsky HI, Kimmel SE. Hemodynamics and Survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003;123:344-50.
4. Gibbs JSR. Recommendation on the management of pulmonary hypertension in clinical practice. Heart 2001;86:1-13.
5. Schachna Lionel, Wigley FM, Chang Betty, White Barbara, Robert A Wise, Gelber C Allan. Age and Risk of Pulmonary Arterial Hypertension in Scleroderma. Chest 2003;124:2098-104.
6. Stupi Angela M, Steen Virginia D , Owens Gregory R, Barnes E Leon , Rodnan Gerald P , Medsger Thomas A Jr. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986;29:515-24.
7. Laing Timothy J, Gillespie Brenda W, Toth Mary B, Mayes Maureen D, Gallavan. Robert H Jr, Burns Carol J, et al. Racial differences in scleroderma among women in Michigan. Arthritis Rheum 1997;40:734-42.
8. Masi T Alfonse, Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
9. Hoeper MM, Oudiz RJ, Peacock A, Tapson VF, Haworth SG, Frost AF, et al. End-point and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspective. J Am Coll Cardiol 2004;43:S48-S55.
10. Yock PG, Popp RL. Noninvasive evaluation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984;70:657-62.
11. Rossa A Della, Valentini G, Bombardieri S, Bencivelli W, Silman A J, D'Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. Clinical and epidemiological features of 290 patients from 19 centers. Annals Rheum Dis 2001;60:585-91.
12. Jacobsen S, Halberg P, Ullman S, Van Venrooij W J, Hoeier-Madsen M, Wiik A, et al. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol 1998;37:39-45.
13. Steen VD, Powell DL, Medsger TA Jr. Clinical correlation and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988;31:196-203.
14. Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, et al. detection of pulmonary arterial hypertension in systemic sclerosis. Arthritis Rheum 2005;52:3792-800.
15. Mukherjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of registry approach. Ann Rheum Dis 2003;62:1088-93.
16. Murata I, Kihara H, Shinohara S, Ito K. Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes. Jpn Circ J 1992;56:983-91.
17. Wigley FM, Lima Joao A.C, Mayes Maureen, McLain David, Chapin J. Lincoln, Ward-Ableet Clive. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community - based rheumatologists (the UNCOVER study). Arthritis Rheum 2005;52:2125-32.
18. Mukherjee D, St. George D, Knight C, Davar J, Wells AU DuBois RM, Black CM, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 2004;43:461-6.
19. Denton CP, Black CA. Pulmonary hypertension in systemic sclerosis. Rheum Dis Clin North Am 2003;29:335-49,vii.
20. Walker UA, Tyndall A, Czirják L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2007;66:754-63.
21. Trad S, Amoura Z, Beigelman C, Haroche J, Costedoat N, Boutin LTHD, et al. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum 2006;54:184-91.
22. Moreau P, d'Uscio LV, Lüscher TF. Structure and reactivity of small arteries in aging. Cardiovasc Res 1998;37:247-53.
23. Yung RL. Changes in immune function with age. Rheum Dis Clin North Am 2000;26:455-73.
24. Launay D, Mouthon L, Hachulla E, Pagnoux Christian, Groote de Pascal, Rami- Jardin Martine, et al. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. J Rheumatol 2007;34:1005-11.
25. Plastiras SC, Karadimitrakis SP, Kampolis C, Moutsopoulos HM, Tzelepis GE. Determinants of pulmonary arterial hypertension in scleroderma. Seminar Arthritis Rheum 2007;36:392-96.